Bruker Daltonics Q2 Earnings Reflect Rising Sales | GenomeWeb

NEW YORK, Aug. 7 – Bruker Daltonics reported second-quarter 2001 revenues of $22.3 million, compared with $17.5 million the company posted one year ago, as it continued to record strong sales of its mass spectrometers designed to analyze proteins and other biomolecules.

Sales of Bruker Daltonics’ life science mass spectrometry systems contributed to 75 percent of the company’s total revenue, with substance detection and aftermarket revenue contributing the remainder.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.